nach oben

Clinical Rheumatology

Erschienen in:

29.01.2018 | Editorial

Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis

verfasst von: Antonio Del Puente, Antonella Esposito, Luisa Costa, Francesco Caso, Raffaele Scarpa

Erschienen in: Clinical Rheumatology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

The attempt to mathematicise the cognitive approach to reality can be traced back to ancient Greek culture. Mathematics is a most powerful cognitive tool, whose potential is evoked by the name itself, as mathesis means “learning reality”. Actually, and surprisingly enough, reality reveals a peculiar correspondence between this approach and its intrinsic constitutive mechanisms, and the development of a favorable cultural context has disclosed the operative potential of this approach. The link between science and praxis has changed completely our relationship with reality. Mathematization has been a driving element also in the field of medical care, generating levels of progress that have recently involved also the strict clinical milieu. …

Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48. https://doi.org/10.1002/art.1780380107 CrossRefPubMed

Kanis JA, Borgstrom F, De Laet C, et al (2005) Assessment of fracture risk. Osteoporos Int 16:581–589

Singh JA, Saag KG, Bridges SL Jr et al (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1–26PubMed

Ranzolin A, Brenol JC, Bredemeier M et al (2009) Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 61(6):794–800. https://doi.org/10.1002/art.24430 CrossRefPubMed

Pincus T, Bergman MJ, Yazici Y (2015) Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis? Clin Exp Rheumatol 33(5 Suppl 93):S82–S93PubMed

Klareskog L, van der Heijde D, de Jager JP et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet 363:675–681CrossRefPubMed

Bruynesteyn K, van der Heijde D, Boers M et al (2002) Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 46:913–920CrossRefPubMed

Yazici Y, Yazici H (2008) Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis. Clin Exp Rheumatol 26(3):449–452PubMed

Medical Professionalism Project (2002) Medical professionalism in the new millennium: a physicians' charter. Lancet 359:520–522CrossRef

10.

Kanis JA, EV MC, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57CrossRefPubMed

11.

Camporro F, Redondo L, Bulacio E, Gutiérrez Magaldi I, Chamale E, Sáenz F (2015) Comparison of FRAX score without bone mineral density determination and the criteria proposed by the argentine osteoporosis society for the use of antiresorptive therapy in postmenopausal women. Medicina (B Aires) 75(3):155–158

12.

Adami S, Bertoldo F, Gatti D et al (2013) Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. Calcif Tissue Int 93:195–200CrossRefPubMed

13.

Beattie K, Adachi J, Ioannidis G et al (2015) Estimating osteoporotic fracture risk following a wrist fracture: a tale of two systems. Arch Osteoporos 10:13CrossRefPubMedPubMedCentral

14.

Reginster JY, Neuprez A, Lecart MP et al (2015) Osteoporosis and personalized medicine. Rev Med Liege 70:321–324PubMed

15.

Kanis JA, McCloskey E, Branco J et al (2014) Goal-directed treatment of osteoporosis in Europe. Osteoporos Int 25:2533–2543CrossRefPubMed

16.

Agenzia Italiana del Farmaco (AIFA) (2017) Aggiornamento Nota 79. http://www.aifa.gov.it/sites/default/files/Determinazione_446-2017_agg_nota79.pdf. Accessed 5 Sept 2017

17.

Hartzband P, Groopman J (2009) Money and the changing culture of medicine. N Engl J Med 360(2):101–103. https://doi.org/10.1056/NEJMp0806369 CrossRefPubMed

18.

Smith R (2001) Why are doctors so unhappy? BMJ 322(7294):1073–1074. https://doi.org/10.1136/bmj.322.7294.1073 CrossRefPubMedPubMedCentral

19.

Rosenthal DI, Verghese A (2016) Meaning and the nature of physicians’ work. N Engl J Med 375(19):1813–1815. https://doi.org/10.1056/NEJMp1609055 CrossRefPubMed

20.

Porter ME (2009) A strategy for health care reform. Toward a value-based system. N Engl J Med 361(2):109–112. https://doi.org/10.1056/NEJMp0904131 CrossRefPubMed

Titel: Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis
verfasst von: Antonio Del Puente
Antonella Esposito
Luisa Costa
Francesco Caso
Raffaele Scarpa
Publikationsdatum: 29.01.2018
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 3/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-018-3995-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

26.04.2024 | Hüft-TEP | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Therapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study

Pregnancy in rheumatoid arthritis: a retrospective study

Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study

Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998–2015

Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?

Influence of air pollution on airway inflammation and disease activity in childhood-systemic lupus erythematosus

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Update Innere Medizin